Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

Money / PACs

Pharmaceutical Research & Manufacturers of America

Trade association PAC FEC C00021972

Influence at a glance · Jan 2025 – Sep 2026Jan 25 – Sep 26 How we count
PAC giving to candidates$261K
Trade association lobbying, all issues $64.5M

Giving: FEC filings, net of refunds. Lobbying: the trade association’s own LD-2 reports, all issues, rounded to the nearest $10,000 each quarter. Two different filers, same 21 months.Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the trade association’s employees or members; the trade association itself can’t give to campaigns from its treasury.

Lobbying spend by quarter since 2015Spend by quarter Pro

Free account See Pro

What they lobby on

Method

Pharmaceutical Research & Manufacturers of America reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 29 outside firms. What follows is what the filings say it lobbied on, not which way.

Issue areas ranked by quarters filedQ4 24 → Q3 26

  • Budget/Appropriations8 of 88/8
  • Copyright/Patent/Trademark8 of 88/8
  • Defense8 of 88/8
  • Health Issues8 of 88/8
  • Medicare/Medicaid8 of 88/8
Pharmacy 8 of 8 · Trade (domestic/foreign) 8 of 8 · 2 more · Show all 9
  • Pharmacy8 of 88/8
  • Trade (domestic/foreign)8 of 88/8
  • Foreign Relations2 of 82/8
  • Taxation/Internal Revenue Code2 of 82/8

Bills named in the filings 202 bills, this period

197 more, 86 named in only one filing · Show all 202

From the filings

“Patent rights. Merchant rights. S.1097 - Interagency Patent Coordination and Improvement Act of 2025.”
Q3 2026 filing · Copyright/Patent/Trademark
“Issues related to competition pracitces in the pharmaceutical marketplace. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.2658 - Medication Affordability and Patent Integrity Act (MAPIA). S.1095 - Stop STALLING Act. S.43 - Skinny Labels, Big Savings Act.”
Q3 2026 filing · Pharmacy

Contacted as listed on the filings

  • U.S. House
  • U.S. Senate
  • Centers For Medicare and Medicaid ServicesCMS
  • Food & Drug AdministrationFDA
  • Health & Human ServicesHHS
  • Natl Economic CouncilNEC
  • Patent & Trademark OfficePTO
  • Executive Office of the PresidentEOP
  • CommerceDOC
  • Treasury
  • Office of Management & BudgetOMB
  • Federal Trade CommissionFTC
  • 5 more

The House and Senate appear in every quarter; agencies in all 8 quarters.

Every filing since 2015, with the lobbyists named and the quarters each bill appearsEvery filing since 2015 Pro

Free account See Pro

Source: Lobbying Disclosure Act filings (LD-2) by Pharmaceutical Research & Manufacturers of America, Senate Office of Public Records. Filings are due 20 days after each quarter ends.

From FEC filings: direct gifts this PAC reported, net of refunds · How we count

Gave directly to 126 sitting members of Congress and 1 other candidate in 2025–26.

Everyone this PAC fundsPro

See every candidate and member Pharmaceutical Research & Manufacturers of America gave to directly, how much, and how its money splits between the parties.

This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.

Create a free account See what Pro adds Log in